|
Chlamydia trachomatis (CT) + Neisseria gonorrhoeae (NG), NAT B11Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) |
|
CK-MB Activity K15CKMB Activity |
|
Clinical Chemistry K01/K02Albumin, alkaline phosphatase (AP), amylase, pancreatic ... |
|
Clinical Chemistry K34Bicarbonate, Cholinesterase, Copper, Fructosamine, Lipase, ... |
|
Clostridium difficile, NAT B13Clostridium difficile |
|
CMV Amplification and nucleic acid detection qn V02Cytomegalovirus, amplification quantitativ |
|
CMV Antibodies B07Cytomegalovirus IgG, IgM |
|
CO-Oximetry K54CO-Oximetry for Cobas b123, Cobas b221, GEM, RAPIDpoint |
|
Coagulation Apixaban G20Anti-FXa-activity Apixaban/Eliquis |
|
Coagulation D-Dimer G06D-Dimer quantitative/qualitative evaluation |
|
Coagulation Dabigatran G22Anti-F2a-activity Dabigatran |
|
Coagulation Edoxaban G21Anti-FXa-activity Edoxaban/Lixiana |
|
Coagulation INR CoaguChek XS Plus G11INR value |
|
Coagulation INR Lumira DX G17INR value |
|
Coagulation INR, Hemochron Jr. G12INR value |
|
Coagulation INR, LabPad G23INR value |
|
Coagulation INR, microINR G14INR value |
|
Coagulation LMWH G18Anti-FXa-activity LMW Heparin |
|
Coagulation oral anticoagulation G01Coagulation in patients on oral anticoagulation: INR, aPTT, ... |
|
Coagulation Rivaroxaban G19Anti-FXa-activity Rivaroxaban/Xarelto |
|
Coagulation therapeutic heparinization G04Coagulation in patients under therapy with unfractionated ... |
|
Coagulation without anticoagulation G03Coagulation in patients without anticoagulation: Quick, ... |
|
Coagulation Xprecia Stride G16INR value |
|
Copeptin K52Copeptin |